108 related articles for article (PubMed ID: 1836334)
1. Changes in endothelial vasoactive substances under recombinant human erythropoietin therapy in hemodialysis patients.
Takayama K; Nagai T; Kinugasa E; Akizawa T; Koshikawa S
ASAIO Trans; 1991; 37(3):M187-8. PubMed ID: 1836334
[TBL] [Abstract][Full Text] [Related]
2. [Changes in endothelial vasoactive substances and blood coagulation and fibrinolysis functions under recombinant human erythropoietin therapy in hemodialysis patients].
Takayama K
Nihon Jinzo Gakkai Shi; 1993 Feb; 35(2):179-88. PubMed ID: 8315881
[TBL] [Abstract][Full Text] [Related]
3. Increased endothelin: nitric oxide ratio is associated with erythropoietin-induced hypertension in hemodialysis patients.
Shimada N; Saka S; Sekizuka K; Tanaka A; Takahashi Y; Nakamura T; Ebihara I; Koide H
Ren Fail; 2003 Jul; 25(4):569-78. PubMed ID: 12911161
[TBL] [Abstract][Full Text] [Related]
4. Effect of subcutaneous and intraperitoneal administration of recombinant human erythropoietin on blood pressure and vasoactive hormones in patients on continuous ambulatory peritoneal dialysis.
Lai KN; Lui SF; Leung JC; Law E; Nicholls MG
Nephron; 1991; 57(4):394-400. PubMed ID: 1828543
[TBL] [Abstract][Full Text] [Related]
5. [The changes in serum TXB2 and 6-keto-PGF1 alpha in 62 cases with renal disease].
Zhang ZF; Zhao YT; Shi XY
Zhonghua Nei Ke Za Zhi; 1989 Jan; 28(1):25-7, 62. PubMed ID: 2737033
[TBL] [Abstract][Full Text] [Related]
6. Intravenous erythropoietin (rHuEPO) administration increases plasma endothelin and blood pressure in hemodialysis patients.
Carlini R; Obialo CI; Rothstein M
Am J Hypertens; 1993 Feb; 6(2):103-7. PubMed ID: 8471228
[TBL] [Abstract][Full Text] [Related]
7. [Effects of Electroacupuncture Stimulation of "Neiguan" (PC 6) at Different Frequencies on Plasma Vasoactive Substance Levels in Myocardial Ischemic Reperfusion Rats].
Wang SK; Lu C; Wang YJ
Zhen Ci Yan Jiu; 2015 Oct; 40(5):378-82. PubMed ID: 26669194
[TBL] [Abstract][Full Text] [Related]
8. The rate of increase in hematocrit, humoral vasoactive substances and blood pressure changes in hemodialysis patients treated with recombinant human erythropoietin or blood transfusion.
Ono K; Hisasue Y
Clin Nephrol; 1992 Jan; 37(1):23-7. PubMed ID: 1531789
[TBL] [Abstract][Full Text] [Related]
9. Evidence for amelioration of endothelial cell dysfunction by erythropoietin therapy in predialysis patients.
Kuriyama S; Hopp L; Yoshida H; Hikita M; Tomonari H; Hashimoto T; Sakai O
Am J Hypertens; 1996 May; 9(5):426-31. PubMed ID: 8735172
[TBL] [Abstract][Full Text] [Related]
10. [Plasma level and effects of thromboxane A2 and 6-keto-PGF1 alpha in patients with acute obstructive suppurative cholangitis].
Miao XY
Zhonghua Wai Ke Za Zhi; 1990 Apr; 28(4):228-30, 253-4. PubMed ID: 2379443
[TBL] [Abstract][Full Text] [Related]
11. Influence of recombinant human erythropoietin therapy on plasma endothelin-1 levels during hemodialysis.
Stefanidis I; Mertens PR; Wurth P; Bach R; Makropoulos W; Mann H; Heintz B
Int J Artif Organs; 2001 Jun; 24(6):367-73. PubMed ID: 11482502
[TBL] [Abstract][Full Text] [Related]
12. [The level of thromboxane A2 and prostacyclin in patients with chronic kidney failure undergoing hemodialysis].
Rud'ko IA; Kubatiev AA; Tsalenchuk IaP; Stel'makov BG
Ter Arkh; 1991; 63(6):66-8. PubMed ID: 1948751
[TBL] [Abstract][Full Text] [Related]
13. Secular trends in recombinant erythropoietin therapy among the U.S. hemodialysis population: 1990-1996.
Cotter DJ; Thamer M; Kimmel PL; Sadler JH
Kidney Int; 1998 Dec; 54(6):2129-39. PubMed ID: 9853279
[TBL] [Abstract][Full Text] [Related]
14. [Effect of glycerol-induced acute renal failure in rabbit with Ligusticum wallichii on thromboxane B2, 6-keto-prostaglandin F1 alpha/thromboxane B2].
Hu WL; Ma YJ
Zhongguo Zhong Xi Yi Jie He Za Zhi; 1993 Sep; 13(9):549-50, 518. PubMed ID: 8111216
[TBL] [Abstract][Full Text] [Related]
15. [A study of the role of plasma thromboxane B2 and 6-keto-prostaglandin F1 alpha in epidemic hemorrhagic fever].
Wang GQ; Zou ZZ; Yu DP
Zhonghua Nei Ke Za Zhi; 1990 Mar; 29(3):138-40, 188. PubMed ID: 1976492
[TBL] [Abstract][Full Text] [Related]
16. [The effect of recombinant human erythropoietin on thrombocyte aggregation capacity and on the blood prostanoid level in patients with chronic kidney failure on hemodialysis].
Rud'ko IA; Pokrovskiĭ IuA; Ermolenko VM; Kubatiev AA
Ter Arkh; 1991; 63(10):128-30. PubMed ID: 1805410
[TBL] [Abstract][Full Text] [Related]
17. Echocardiographic findings in hemodialysis patients treated with recombinant human erythropoietin: proposal for a hematocrit most beneficial to hemodynamics.
Tagawa H; Nagano M; Saito H; Umezu M; Yamakado M
Clin Nephrol; 1991 Jan; 35(1):35-8. PubMed ID: 2007294
[TBL] [Abstract][Full Text] [Related]
18. [Clinical study on improving effect of Buyang Huanwu decoction on plasma thromboxane B2, 6-keto-prostaglandin F1 alpha, endothelin and calcitonin gene related peptide in primary nephrotic syndrome patients].
Wu Y; Yang J; Jiang L
Zhongguo Zhong Xi Yi Jie He Za Zhi; 1998 Dec; 18(12):715-7. PubMed ID: 11475715
[TBL] [Abstract][Full Text] [Related]
19. [Efficacy and safety of long-term erythropoietin therapy in chronic hemodialysis patients with renal anemia].
Ohkubo M; Ishimitsu T; Kawaguchi T; Abe M; Yagi S
Nihon Jinzo Gakkai Shi; 1993 Feb; 35(2):171-7. PubMed ID: 8315880
[TBL] [Abstract][Full Text] [Related]
20. Erythropoietin with oral iron in peritoneal and hemodialysis patients. A comparison in an inner city population.
Raja R; Bloom E; Goldstein M; Johnson R
ASAIO J; 1993; 39(3):M578-80. PubMed ID: 8268603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
